Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Target Volume”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT05331833
What this trial is testing

Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.

Who this might be right for
Stage III Non-small-cell Lung Cancer
Jianguo Sun 90
Large-scale testing (Phase 3)Looking for participantsNCT07661771
What this trial is testing

Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma

Who this might be right for
Non-metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 568
Testing effectiveness (Phase 2)Looking for participantsNCT06563362
What this trial is testing

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

Who this might be right for
Oropharynx Cancer
University of Zurich 120
Not applicableUnknownNCT02627807
What this trial is testing

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 386
Not applicableUnknownNCT05512195
What this trial is testing

Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma

Who this might be right for
Glioblastoma
Zhongnan Hospital 70
Testing effectiveness (Phase 2)Study completedNCT02916511
What this trial is testing

Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 70
Not applicableStudy completedNCT03505112
What this trial is testing

The Effect of Goal-directed Hemodynamic Therapy in Radical Cystectomy

Who this might be right for
Bladder CancerRadical Cystectomy
Seoul National University Hospital 82
Not applicableUnknownNCT04745741
What this trial is testing

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 200
Testing effectiveness (Phase 2)UnknownNCT04543890
What this trial is testing

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Zhejiang Cancer Hospital 300
Not applicableLooking for participantsNCT06719440
What this trial is testing

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

Who this might be right for
GlioblastomaRadiotherapy Side Effect
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 347
Not applicableLooking for participantsNCT06037733
What this trial is testing

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Who this might be right for
Advanced Non-Small Cell Squamous Lung CancerRadiotherapyImmunotherapy
Hubei Cancer Hospital 134
Early research (Phase 1)Study completedNCT01028885
What this trial is testing

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+2 more
Abramson Cancer Center at Penn Medicine 10
Large-scale testing (Phase 3)Looking for participantsNCT07188584
What this trial is testing

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen 166
Not applicableUnknownNCT04654520
What this trial is testing

Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC

Who this might be right for
RadiotherapyNonsmall Cell Lung Cancer, Stage IV
Guizhou Medical University 290
Not applicableEnded earlyNCT02666404
What this trial is testing

Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in Shock

Who this might be right for
Shock
University Hospital, Basel, Switzerland 49
Not applicableNot Yet RecruitingNCT05909137
What this trial is testing

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
ImmunotherapyIntensity Modulated Radiation TherapyRadiotherapy+1 more
Xinqiao Hospital of Chongqing 60
Large-scale testing (Phase 3)Looking for participantsNCT07008716
What this trial is testing

Omitting CTV for Primary Tumor in LS-SCLC

Who this might be right for
SCLC, Limited StageRadiation ExposureRadiotherapy Side Effect+1 more
Sun Yat-sen University 852
Not applicableStudy completedNCT00608920
What this trial is testing

Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping

Who this might be right for
Adenocarcinoma of the Prostate
Washington University School of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT00230438
What this trial is testing

External Beam Radiation Therapy - Target Volume

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 27
Not applicableLooking for participantsNCT06167109
What this trial is testing

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Chongqing University Cancer Hospital 60
Next Page